| Name | | |
| Last NAV | 31.51 | 91.83 |
| Date of Valuation | 2019/11/14 | 2019/11/14 |
| Sharpe Ratio | N/A | 0.60 |
| 3-Year Risk Return Ratio | 0.13 | 0.69 |
| Cumulative Performance (%) |
| +8.92% | +8.21% |
| +6.06% | +9.69% |
| +6.52% | +14.05% |
| +19.00% | +22.65% |
| -16.31% | -15.10% |
| -17.87% | +29.50% |
| +34.70% | -33.70% |
| +215.10% | N/A |
| Calendar Year Performance (%) |
| -16.31% | -15.10% |
| +16.93% | +20.70% |
| -17.87% | +29.50% |
| +4.93% | -9.20% |
| +34.70% | -33.70% |
| 3-Year Annualised Volatility | 15.19% | 15.22% |
| Funds House | Franklin Templeton Investments (Asia) Ltd | Baring Asset Management (Asia) Limited |
| Portfolio Manager | Evan McCulloch & Wendy Lam & Steve Kornfeld | Matthias Siller & Adnan El-Araby & Maria Szczesna |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 1620000000 | USD 87320000 |
| Base Currency | USD | USD |
| Sector | Biotechnology | General |
| Geographic Allocation | US | Eastern Europe |
| Top Holdings |
| ALEXION PHARMACEUTICALS INC (4.31%) | Komercni banka (3.20%) |
| AMGEN INC (7.74%) | Sberbank (9.40%) |
| VERTEX PHARMACEUTICALS INC (6.08%) | Novatek (8.90%) |
| BIOGEN INC (4.11%) | Gazprom (9.60%) |
| ILLUMINA INC (4.93%) | X5 (5.00%) |
| GW PHARMACEUTICALS PLC (3.24%) | Oil company LUKOIL (6.10%) |
| REGENERON PHARMACEUTICALS INC (3.07%) | PZU (4.90%) |
| BIOMARIN PHARMACEUTICAL INC (3.00%) | KGHM Polska Miedz (3.30%) |
| IOVANCE BIOTHERAPEUTICS INC (3.38%) | Santander Bank Polska (3.10%) |
| GILEAD SCIENCES INC (5.34%) | Mail.ru (3.20%) |
| Minimum Initial Investment | USD 1000 | USD 5000 |
| Initial Sales Fee | Class A: Up to 5.00%. Class B: Nil | Class A Units: up to 5% of the amount you subscribed.Class I Units: Nil. |
| Switching Fee | Class A: 1.00%. Class B: Nil | Nil |
| Maintenance Fee | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%. Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. | Trustee fee:0.025%,subject to monthly minimum fee of £500.Administration fee：0.45%, subject to monthly minimum fee of £2,500.Transaction fee:£50 per security ransaction. |
| Redemption Fee | Class A: Nil. Class B: Up to 4.00% | Nil |
| Launch Date | 2000/04/03 | 1996/09/30 |
| End of Financial Year | 30/06 | 30/4 |
| Country of Registry | Luxembourg | Ireland |
| Other Relevant Information | | |
| |
